Overview

Expanding the Pool in Lung Transplantation

Status:
Active, not recruiting

Trial end date:
2026-02-01

Target enrollment:

Participant gender:

Summary

To perform a study (20 patients) utilizing Hepatitis C positive (HCV Ab+/NAT -) donor lungs for hepatitis C negative recipients with post-operative surveillance and treatment only if a recipient infection occurs.

Phase:

Phase 1

Details

Lead Sponsor:

Pablo Sanchez

Treatments:

Sofosbuvir
Sofosbuvir-velpatasvir drug combination
Velpatasvir